Christopher Peetz

Director, CHIEF EXECUTIVE OFFICER · 1 filing · Latest: Mar 15, 2026

Mirum Pharmaceuticals, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MIRM	Christopher Peetz	Director, CHIEF EXECUTIVE OFFICER	Mar 16, 2026	Sale	$91.98	40,985	$3.8M	194,309	Mar 17 11:30 PM
MIRM	Christopher Peetz	Director, CHIEF EXECUTIVE OFFICER	Mar 15, 2026	Option Exercise	—	75,000	—	235,294	Mar 17 11:30 PM